Organovo announces ability to print 3D human liver tissue

Organovo announces ability to print 3D human liver tissue
The NovoGen Bioprinter fabricating tissue into a 24-well plate.

(Medical Xpress)—Organovo Holdings, Inc., a company that designs and creates functional human tissue has announced at this year's Experimental Biology Conference that it has developed a 3D printing technique that is able to produce small samples of human liver tissue. They claim their new process allows for printing 500 micron thick liver tissue, amounting to 20 cell layers, which is able to produce cholesterol and some of the enzymes produced by the natural liver. The liver samples produced, the company said, can be used by researchers looking to test the efficacy of new drugs designed to treat liver diseases or to test side effects on the liver of drugs created for other purposes.

Currently, companies that develop drugs to treat must rely on 2D tissue samples, which most admit are not optimal. For that reason, many drugs that pass such tests eventually fail trials in live patients. As a result, pharmaceutical companies have been eager to find a better replacement.

The process of creating human tissue is one still very much under development. Researchers use various chemicals to coax cells taken from real livers and stem cells to grow tissue that resembles the real thing. Unfortunately, until now, the tissues that result have been just single layers of cells, which flatten when placed in a . And while such tissue does generally produce some of the same enzymes as real livers, allowing researchers to see what impact a drug has, most are not near the level of a real liver—the samples also generally only live for a couple of days. In contrast, the new samples printed by Organovo, the company claims, can live for as long as five days or more.

for the company, Sharon Presnell explained to those at the conference that Organovo's 3D printing process involves printing out two different types of —hepatocytes and stellates—along with the linings of . The result is tissue that the company claims looks, feels and in many ways, behaves just like real human liver tissue. They say it can produce albumin, cholesterol and cytochrome P450s (enzymes that metabolize drugs)—and because of that is much better suited for testing new drugs. She added that the new process marks another step towards the creation of full-size human livers for implanting in people to replace those that have failed, and even went so far as to predict that such technology will come to pass in her lifetime.

Organovo's scientific founder, Gabor Forgacs, presents on bioprinting at TEDMED.

Explore further

Artificial liver to replace animal testing, potential to accelerate development of new drugs

More information: Press release

© 2013 Medical Xpress

Citation: Organovo announces ability to print 3D human liver tissue (2013, April 24) retrieved 17 July 2019 from https://medicalxpress.com/news/2013-04-organovo-ability-3d-human-liver.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more